8EQ Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cytek Biosciences Inc

Watchlist Manager

Watchlist

Price: 3.78 EUR 0.53%

Market Cap: €496.2m

	Cytek Biosciences Inc F:8EQ	US
B	Biotest AG F:BIO	DE
V	Vicat SA SWB:4HM	FR
W	Weichai Power Co Ltd OTC:WEICF	CN
	Arqit Quantum Inc NASDAQ:ARQQ	UK
F	Fabrinet F:FAN	KY
H	Hormel Foods Corp F:HO7	US
	Boyd Group Services Inc F:3YT	CA

Profitability Summary

Cytek Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

52%

Strong 3Y Average Gross Margin

55%

Declining Gross Margin

60% > 52%

Negative Operating Margin

-20%

Negative 3Y Average Operating Margin

-14%

Declining Operating Margin

-11% > -20%

Negative Net Margin

-33%

Negative 3Y Average Net Margin

-8%

Declining Net Margin

-3% > -33%

Negative Free Cash Flow Margin

-4%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-6% > -4%

Negative ROE

-18%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-14%

Declining ROIC

-7% > -44%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

52%

Strong 3Y Average Gross Margin

55%

Declining Gross Margin

60% > 52%

Negative Operating Margin

-20%

Negative 3Y Average Operating Margin

-14%

Declining Operating Margin

-11% > -20%